Alerts will be sent to your verified email
Verify Email
KILITCH
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Kilitch Drugs (India) Limited, based in Mumbai, is a pharmaceutical company focusing on manufacturing and marketing antibacterial parenteral formulations including Carbapenems, Cephalosporins, and anti malarials. It transferred some products to Akorn India Pvt. Ltd. in 2012.
Kilitch Drugs(India) major competitors are Ind-Swift Lab., Venus Remedies, Bharat Parenterals, Jenburkt Pharma, Prevest Denpro, Sakar Healthcare, Medicamen Biotech.
Market Cap of Kilitch Drugs(India) is ₹719 Crs.
While the median market cap of its peers are ₹608 Crs.
Kilitch Drugs(India) seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Dec | Mar | Mar | Jun Sep | |||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | Mar | Mar | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
